HealthQuill Cancer
Egypt has been granted a “gold tier” status by the WHO for providing 93% of those diagnosed with hepatitis C with treatment in its path to eliminate the infection.
Drugs Health Pharma

Egypt close to ending hepatitis C, gets WHO ‘gold tier’ status

HQ Team October 9, 2023: Egypt has been granted a “gold tier” status by the WHO for providing 93% of those diagnosed with.

Read More
Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through a combination of cash and debt to broaden its cancer portfolio.
Drugs Health Pharma

Bristol Myers acquires Mirati Therapeutics for $5.8 billion

HQ Team October 9, 2023: Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through.

Read More
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency often ignored by caretakers.
Drugs Health Pharma

US cancer patients using alcohol pose new challenge for caretakers

Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency.

Read More
https://investors.immatics.com/news-releases/news-release-details/moderna-and-immatics-announce-strategic-multi-platform
Drugs Health Pharma

Moderna, Immatics join hands to hunt for cancer therapies using mRNA, AI 

HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a.

Read More
A study on mice has produced a vaccine for Epstein-Barr virus, which is linked to a 32-fold higher risk of developing multiple sclerosis.
Drugs Health Pharma

Vaccine to treat Epstein-Brarr virus developed in mice

HQ Team August 17, 2023: A study on mice has produced a vaccine for Epstein-Barr virus, which is linked to a 32-fold higher.

Read More
Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients with metastatic uveal melanoma, giving the Delaware-based firm $60 million fund access.
Drugs Health Pharma

Delcath Systems gets FDA nod for Hepzato Kit to treat uveal melanoma

HQ Team August 16, 2023: Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients.

Read More
Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which in future can fight cancer and diabetes.
Drugs Health Pharma

Biomedical engineers create ML model to turn genes on and off

HQ Team August 14, 2023: Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which.

Read More
US researchers have developed a targeted chemotherapy method that may decimate all solid tumors in animals at a laboratory, and a trial has started to test it on humans.
Drugs Health Pharma

US researchers develop novel chemotherapy cancer treatment

HQ Team August 5, 2023: US researchers have developed a targeted chemotherapy method that may decimate all solid tumors in animals at a.

Read More
Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to the WHO Essential Medicines List.
Drugs Health Pharma

Cancer, multiple sclerosis, Ebola treatments in new WHO Essential Medicines List

HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to.

Read More
A hunting community, as far as Northeastern Greenland has some of the world’s highest concentrations of harmful polyfluoroalkyl substances (PFAS), a Danish study found.
Climate Drugs Pharma

Greenland’s hunting community reports high PFAS levels

HQ Team July 13, 2023: A hunting community, as far as Northeastern Greenland has some of the world’s highest concentrations of harmful polyfluoroalkyl.

Read More